Published by Frank Prenesti on 28th April 2023
(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance after a stronger-than-expected start to the year for its generics business but expressed concern about the impact of the current conflict in Sudan on operations.
URL: http://www.digitallook.com/dl/news/story/33468085/...